AMENDED AND RESTATED COMMON STOCK PURCHASE WARRANT ALLARITY THERAPEUTICS, INC.Allarity Therapeutics, Inc. • July 11th, 2023 • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time or times on or after April 21, 2023 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on July 10, 2028 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Allarity Therapeutics, Inc., a Delaware corporation (the “Company”), up to _____ shares of common stock, par value $0.0001 per share (the “Common Stock”) (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant supersedes and replaces the original Common Stock Purchase Warrant issued as of April 21, 2023, to purchase ______ (original issuance) shares of common stock of the Company, par v
